ADPEN Laboratories

The Analytical Partner You Trust

  • ABOUT ADPEN
    • CORONAVIRUS UPDATE:
    • Our Staff
    • Our Facilities
    • Our Instrumentation
  • CONTACT ADPEN
    • Request Info or Quote
  • TEST REQUEST FORMS
  • RESOURCES
    • Analytical Services and Testing Brochures
    • Career Opportunities
    • Industry Guidance Documents
    • Terms and Conditions
  • AGROSCIENCES
    • ANALYTICAL TESTING
    • ECOTOX
    • 5-BATCH ANALYSIS
    • PRODUCT CHEMISTRY
  • PHARMACEUTICALS
    • CONTRACT FORMULATION AND MANUFACTURING
    • PHARMACEUTICAL TESTING
    • NITROSAMINE IMPURITIES IN PHARMACEUTICALS
  • FOOD SAFETY
    • NUTRITIONALS
    • FOOD SAFETY TESTING
  • ANIMAL HEALTH
You are here: Home / ALL NEWS / FDA Extends Enforcement Discretion Period for Phytosterol Claims

FDA Extends Enforcement Discretion Period for Phytosterol Claims

March 6, 2012 By Steven Perez

FDA says it will extend the enforcement discretion period for phytosterol-and-heart-disease claims until publication of a final rule.

In September 2000, FDA issued an interim final rule allowing a claim of reduced risk of coronary heart disease (CHD) for eligible products fortified with phytosterols. Since then, parties have petitioned for more eligible products, eligible phytosterols, and eligible phytosterol forms, and the FDA has even increased the required usage levels for phytosterols (0.5 g per RACC) in products bearing the claim. For years, all of this has been subject to an enforcement discretion period during which time manufactures have been allowed to go off of initial phytosterol requirements without penalty.

Most recently, the enforcement discretion period was set to expire on February 21, 2012. Products marketed after this date would have to meet all new changes to bear the heart health claim.

Read more about FDA’s extension of the enforcement period for phytosterol-and-heart-disease claims until publication of a final rule at Nutritional Outlook.com

Filed Under: ALL NEWS, All Services, Analytical Testing News & Updates | ADPEN Laboratories, Nutraceutical Links Tagged With: analysis, Analytical, FDA, GMP, guidance, supplement, Testing

ISO/IEC 17025 ACCREDITED

ISO/IEC 17025 is a company level accreditation based on a standard published by the International Organization for Standardization (ISO) titled “General requirements for the competence of testing and calibration laboratories”. ISO/IEC 17025 is a general umbrella term used to refer to the specific standard; the current version of this standard is ISO/IEC 17025:2017. The standard contains two main sections: management requirements (primarily related to the operation and effectiveness of the quality management system within the laboratory) and technical requirements (primarily related to the competence of staff and calibration of equipment). The standard also gives requirements related to quality management such as document control and corrective action. This standard is the basis for accreditation from an accrediting body.

ADPEN has also been inspected by the US-EPA and US-FDA multiple times with no observations.

Agroscience Links

  • 5-Batch Analytical Services
  • Analytical Testing Brochure
  • Pesticide Residue Analytical Services

Let’s Network!

Follow @AdpenLabs

RSS USEPA- Agriculture News

What Our Clients Say About ADPEN

“Good job by you and ADPEN!” -B.I.

Get in Touch With Us

ADPEN Laboratories, Inc.
11757 Central Parkway
Jacksonville, FL 32224 USA

Phone: 1.904.645.9169
Fax: (904) 641-8423
Contact Form

Copyright © 2021 · Enterprise Pro Theme on Genesis Framework · WordPress · Log in